Home » Topics » Regulatory » Patents

Patents
RSS

More telomerase inhibitors added to the Geron pipeline

June 25, 1998

Substituted carbapenems for Gram-positive infections designed at Merck & Co.

June 24, 1998

Idun discloses new inhibitors of ICE and related proteases

June 24, 1998

Abbott patents improved ketolide antibacterial agents

June 24, 1998

New cell adhesion inhibitors from Chiroscience

June 23, 1998

BioChem Pharma describes lactams for thrombotic disorders

June 23, 1998

Immunosuppressive, antiinflammatory and antitumor rapamycin derivatives

June 23, 1998

PKC inhibitors for inflammatory/immune disorders developed at Astra

June 23, 1998

Lilly expands women's health pipeline

June 23, 1998

Allergan continues to strengthen its position in retinoid R&D

June 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...